<PAGE> 1
EXHIBIT 23.7
CONSENT OF GLEACHER & CO. LLC
We hereby consent to the use of our opinion letter dated June 7, 2000,
to the board of directors of LJL BioSystems, Inc. included in Annex D to the
Proxy Statement-Prospectus which forms a part of the Registration Statement on
Form S-4 relating to the proposed merger described therein and to the references
to such opinion in such Proxy Statement-Prospectus under the captions
"Summary--Opinions of Financial Advisors--Opinion of LJL BioSystems' Financial
Advisor," "The Merger--Background," "The Merger--Reasons for the Merger--LJL
BioSystems' Reasons for the Merger" and "The Merger--Opinion of LJL BioSystems'
Financial Advisor." In giving such consent, we do not admit that we come within
the category of persons whose consent is required under Section 7 of the
Securities Act of 1933, as amended, or the rules and regulations of the
Securities and Exchange Commission thereunder, nor do we thereby admit that we
are experts with respect to any part of such Registration Statement within the
meaning of the term "experts" as used in the Securities Act of 1933, as amended,
or the rules and regulations of the Securities and Exchange Commission
thereunder.
GLEACHER & CO. LLC
June 28, 2000
By: /s/ DAVID W. MILLS
-------------------------
Name: David W. Mills
-----------------------
Title: Managing Director
----------------------
